Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

Yao PL, Morales JL, Zhu B, Kang BH, Gonzalez FJ, Peters JM.

Mol Cancer Ther. 2014 Apr;13(4):1008-17. doi: 10.1158/1535-7163.MCT-13-0836. Epub 2014 Jan 24.

PMID:
24464939
[PubMed - indexed for MEDLINE]
2.

Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.

Girroir EE, Hollingshead HE, Billin AN, Willson TM, Robertson GP, Sharma AK, Amin S, Gonzalez FJ, Peters JM.

Toxicology. 2008 Jan 14;243(1-2):236-43. Epub 2007 Nov 4.

PMID:
18054822
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.

Foreman JE, Sharma AK, Amin S, Gonzalez FJ, Peters JM.

Cancer Lett. 2010 Feb 28;288(2):219-25. doi: 10.1016/j.canlet.2009.07.006. Epub 2009 Aug 5.

PMID:
19660859
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.

Bility MT, Devlin-Durante MK, Blazanin N, Glick AB, Ward JM, Kang BH, Kennett MJ, Gonzalez FJ, Peters JM.

Carcinogenesis. 2008 Dec;29(12):2406-14. doi: 10.1093/carcin/bgn219. Epub 2008 Sep 17.

PMID:
18799709
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.

Suchanek KM, May FJ, Robinson JA, Lee WJ, Holman NA, Monteith GR, Roberts-Thomson SJ.

Mol Carcinog. 2002 Aug;34(4):165-71.

PMID:
12203367
[PubMed - indexed for MEDLINE]
6.

Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.

Bility MT, Zhu B, Kang BH, Gonzalez FJ, Peters JM.

Toxicol Sci. 2010 Jan;113(1):27-36. doi: 10.1093/toxsci/kfp212. Epub 2009 Sep 11.

PMID:
19748995
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.

Pedchenko TV, Gonzalez AL, Wang D, DuBois RN, Massion PP.

Am J Respir Cell Mol Biol. 2008 Dec;39(6):689-96. doi: 10.1165/rcmb.2007-0426OC. Epub 2008 Jun 19.

PMID:
18566335
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.

Burdick AD, Bility MT, Girroir EE, Billin AN, Willson TM, Gonzalez FJ, Peters JM.

Cell Signal. 2007 Jun;19(6):1163-71. Epub 2007 Jan 3.

PMID:
17254750
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.

Foreman JE, Chang WC, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM.

Mol Carcinog. 2011 Nov;50(11):884-900. doi: 10.1002/mc.20757. Epub 2011 Mar 11.

PMID:
21400612
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.

Vanderlaag K, Su Y, Frankel AE, Grage H, Smith R 3rd, Khan S, Safe S.

Breast Cancer Res Treat. 2008 May;109(2):273-83. Epub 2007 Jul 12.

PMID:
17624585
[PubMed - indexed for MEDLINE]
11.

Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.

Foreman JE, Sorg JM, McGinnis KS, Rigas B, Williams JL, Clapper ML, Gonzalez FJ, Peters JM.

Mol Carcinog. 2009 Oct;48(10):942-52. doi: 10.1002/mc.20546.

PMID:
19415698
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.

Borland MG, Foreman JE, Girroir EE, Zolfaghari R, Sharma AK, Amin S, Gonzalez FJ, Ross AC, Peters JM.

Mol Pharmacol. 2008 Nov;74(5):1429-42. doi: 10.1124/mol.108.050609. Epub 2008 Aug 7.

PMID:
18687807
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.

He P, Borland MG, Zhu B, Sharma AK, Amin S, El-Bayoumy K, Gonzalez FJ, Peters JM.

Toxicology. 2008 Dec 5;254(1-2):112-7. doi: 10.1016/j.tox.2008.09.023. Epub 2008 Oct 2.

PMID:
18950674
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.

Zhu B, Bai R, Kennett MJ, Kang BH, Gonzalez FJ, Peters JM.

Mol Cancer Ther. 2010 Dec;9(12):3267-77. doi: 10.1158/1535-7163.MCT-10-0820.

PMID:
21159610
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.

Borland MG, Khozoie C, Albrecht PP, Zhu B, Lee C, Lahoti TS, Gonzalez FJ, Peters JM.

Cell Signal. 2011 Dec;23(12):2039-50. doi: 10.1016/j.cellsig.2011.07.020. Epub 2011 Aug 4.

PMID:
21843636
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.

Gründker C, Föst C, Fister S, Nolte N, Günthert AR, Emons G.

Breast Cancer Res. 2010;12(4):R49. doi: 10.1186/bcr2606. Epub 2010 Jul 14.

PMID:
20630060
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).

Takabatake D, Fujita T, Shien T, Kawasaki K, Taira N, Yoshitomi S, Takahashi H, Ishibe Y, Ogasawara Y, Doihara H.

Int J Cancer. 2007 Jan 1;120(1):181-8.

PMID:
17036319
[PubMed - indexed for MEDLINE]
18.

Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.

Peters JM, Foreman JE, Gonzalez FJ.

Cancer Metastasis Rev. 2011 Dec;30(3-4):619-40. doi: 10.1007/s10555-011-9320-1. Review.

PMID:
22037942
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.

Hollingshead HE, Killins RL, Borland MG, Girroir EE, Billin AN, Willson TM, Sharma AK, Amin S, Gonzalez FJ, Peters JM.

Carcinogenesis. 2007 Dec;28(12):2641-9. Epub 2007 Aug 11.

PMID:
17693664
[PubMed - indexed for MEDLINE]
Free Article
20.

The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.

Zhu B, Ferry CH, Markell LK, Blazanin N, Glick AB, Gonzalez FJ, Peters JM.

J Biol Chem. 2014 Jul 18;289(29):20102-19. doi: 10.1074/jbc.M114.551069. Epub 2014 Jun 4.

PMID:
24898257
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk